Treatment of experimental leishmaniasis with the immnnomodulators imiquimod and S-28463: Efficacy and mode of action

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1485-1494

  Buates, Sureemas ^a   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; GAMMA INTERFERON; IMIQUIMOD; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; RESIQUIMOD; UNCLASSIFIED DRUG;

ARTICLE; CONDYLOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; IMMUNOMODULATION; LEISHMANIASIS; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYRIAN HAMSTER;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; BONE MARROW CELLS; FEMALE; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGES; MICE; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; TRYPANOCIDAL AGENTS;

EID: 0033057209     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314782     Document Type: Article

References (23)

1. 1. Modabber F. Leishmaniasis. In: Tropical diseases research progress 1991-1992. Walgate R, Simpson K, eds. Geneva: World Health Organization, 1995:77-88.
2. 2. World Heath Organization. Thirteenth programme report. Special programme for research and training in tropical diseases, Leishmaniasis. Geneva: WHO Publications, 1997:100-11.
3. 3. Molyneux D, Killick-Kendrick R. Morphology, ultrastructure and life cycles. In: Peters W, Killick-Kendrick R, eds. The leishmaniasis in biology and medicine. Vol. 1. Biology and epidemiology. London: Academic Press, 1987:121-76.
4. 4. Baily G, Nandy A. Visceral leishmaniasis: more prevalent and more problematic. J Infect 1994;29:241-7.
5. 5. Olliaro PL, Bryceson AD. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 1993;9:323-32.
6. 6. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
7. 7. Reiter M, Testerman T, Miller R, Weeks C, Tomai M. Cytokine induction in mice by the immunomodulator imiquimod. J Leukok Biol 1994;55: 234-40.
8. 8. Tomai M, Gibson S, Imbertson L, et al. Immunomodulating and antiviral activities of the imidazoquinoline S-28463. Antiviral Res 1995;28:253-64.
9. 9. Testermon T, Gerster J, Imbertson L, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukok Biol 1995;58:365-72.
10. 10. Charest H, Matlashewski G. Developmental gene expression in Leishmania donovani differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 1994;14:2975-84.
11. 11. Descoteaux A, Matlashewski G. c-fos and TNF gene expression in Leishmania donovani infected macrophages. Mol Cell Biol 1989;9:5223-7.
12. 12. Moore K, Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994;152:2930-7.
13. 13. Guy R, Belosevic M. Response of scid mice to establishment of Leishmmania major infection. Clin Exp Immunol 1995;100:440-5.
14. 14. Wel X-Q, Charles G, Smith A, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-11.
15. 15. Ding A, Nathan C, Stuehr D. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1998;141:2407-12.
16. 16. Chirgwin M, Przybyla A, MacDonald R, Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
17. 17. Green S, Nacy C, Meltzer M. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukok Biol 1991;50:93-103.
18. 18. Vouldoukis I, Riveros-Moreno V, Dugas B, et al. The killing of Leishmania major by macrophages is mediated by nitric oxide induced after ligation of the Fe epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA 1995;92:7804-8.
19. 19. Vouldoukis I, Becherel P, Riveros-Moreno V, et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum und Leishmania major by human macrophages by decreased nitric oxide generation. Eur J Immunol 1997;27:860-5.
20. 20. Lowenstein C, Allen E, Raval P, et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-γ and lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:8730-4.
21. 21. Ricote M, Li A, Willson T, Kelly C, Glass C. The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation. Nature 1998;391:79-82.
22. 22. May M, Ghosh S. Signal transduction through NF-ΚB. Immunol Today 1998;19:80-8.
23. 23. Megyeri K, Au W, Rosztoczy V, et al. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by sendai virus utilize similar signal transduction pathways. Mol Cell Biol 1995;15:2207-18.